» Articles » PMID: 35692550

Case Report: A Missense Mutation of in Hyperpigmentation and Lentigines Unassociated With Systemic Disorders: Report of a Chinese Pedigree and a Literature Review

Overview
Specialty General Medicine
Date 2022 Jun 13
PMID 35692550
Authors
Affiliations
Soon will be listed here.
Abstract

Background: is a proto-oncogene that is involved in the proliferation, survival, and regulation of melanocytes, mast cells, and the interstitial cells of Cajal. Mutations of have been reported to be associated with hyperpigmentation and lentigines, mastocytosis, and gastrointestinal stromal tumors (GISTs). Some hotspot mutations of have been reported to be associated with mastocytosis and GISTs, while the relationship between mutations and hyperpigmentation and lentigines has not been fully elucidated.

Methods: In this study, we presented a three-generation Chinese pedigree with progressive hyperpigmentation and generalized lentigines inherited in an autosomal dominant pattern. High-throughput sequencing was performed to capture genetic variations in peripheral blood samples of the proband. Also, Sanger sequencing was performed to further verify the result. We also reviewed previous literature on mutations with hyperpigmentation and lentigines.

Results: A missense mutation of the gene was identified: c. 2485G > C, which was co-segregated in the proband and his insulted father. Germline mutations presenting as generalized hyperpigmentation and lentigines without systemic disorders are rare, with only two reports of c. 2485G > C mutation associated with this phenotype in previous literature.

Conclusion: Our pedigree, together with those two reports, indicates a possible phenotype-genotype correlation of this germline mutation, which might be helpful for genetic counseling, further functional segregation of KIT, and design of targeted therapy in the future.

Citing Articles

Chinese Pedigree with Hereditary Gastrointestinal Stromal Tumors: A Case Report and Literature Review.

Ge Q, Liu Y, Yang F, Sun G, Guo J, Sun S Int J Mol Sci. 2023; 24(1).

PMID: 36614290 PMC: 9820900. DOI: 10.3390/ijms24010830.

References
1.
Tran A, Pearce A, Lopez-Sanchez M, Perez-Jurado L, Barnett C . Novel KIT mutation presenting as marked lentiginosis. Pediatr Dermatol. 2019; 36(6):922-925. DOI: 10.1111/pde.13952. View

2.
Jiang X, Lin Z, Wang H . Multiple lentigines and cutaneous hyperpigmentation caused by a KIT mutation. Br J Dermatol. 2020; 183(5):e148. DOI: 10.1111/bjd.19295. View

3.
Hasegawa M, Shimizu A, Ieta K, Shibusawa K, Ishikawa O, Ishida-Yamamoto A . Generalized lentigines associated with familial gastrointestinal stromal tumors dramatically improved by imatinib treatment. J Dermatol. 2020; 47(6):e241-e242. DOI: 10.1111/1346-8138.15321. View

4.
Delyon J, Lebbe C, Dumaz N . Targeted therapies in melanoma beyond BRAF: targeting NRAS-mutated and KIT-mutated melanoma. Curr Opin Oncol. 2019; 32(2):79-84. DOI: 10.1097/CCO.0000000000000606. View

5.
Shibusawa Y, Tamura A, Mochiki E, Kamisaka K, Kimura H, Ishikawa O . c-kit Mutation in generalized lentigines associated with gastrointestinal stromal tumor. Dermatology. 2004; 208(3):217-20. DOI: 10.1159/000077302. View